MRI correlates of disability progression in patients with CIS over 48 months.
about
Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis.Structural Brain Network Characteristics Can Differentiate CIS from Early RRMSDecreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients.Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.Midsagittal corpus callosum area and conversion to multiple sclerosis after clinically isolated syndrome: A multicentre Australian cohort study.Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling.Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients.Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome.Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression.Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination.Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.
P2860
Q35997017-BDBF8658-C1F2-4BC3-B71E-C4AB1853EAE7Q36211674-CA60EDF4-EBDF-46FB-99F6-F7AA83E1B5B7Q36527375-B5FABB0C-9919-40DB-B1F3-6AF7651AB3CEQ38299101-7AF98A56-25CB-4C8E-A411-549D5EED3AFBQ38654791-C16F43A5-786C-4B4B-8D7D-4C736C6243BDQ38777286-26B80DB1-5A91-4CF6-B49E-1F6A3FA67F12Q38808604-0239C9C6-943A-4679-AAA1-F6836C2EE4E2Q39044303-EA7653FD-518A-40EA-93DA-434294706DBAQ41999269-C24B0740-C7B0-475A-92F3-D17A4A38109EQ47639943-87F8F8EE-979D-4CE5-91EF-3329929BD894Q47924597-52634572-E493-422A-9A14-DD26EA405EF3Q47967210-CDBCC510-73E5-4D2D-8443-2A6E2A1E5792Q48108313-D19A75F4-BE5D-498E-9E97-2602257AA3EDQ48215414-1699FF68-55A8-459D-8346-DB6B90B3693EQ48257014-9D8C1765-40AD-45EC-91A2-8B9C5BAA22EFQ48581094-C97E6085-7D0E-4700-A350-706A9E3D4FABQ48711608-5D565453-5765-4490-AB69-73984AC71C7CQ52149413-C0FBCFFA-29BA-4D65-9965-38907981B2C9Q52149416-76B8E2A4-9CD6-40E3-AAF5-E52522DA5B96
P2860
MRI correlates of disability progression in patients with CIS over 48 months.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MRI correlates of disability progression in patients with CIS over 48 months.
@ast
MRI correlates of disability progression in patients with CIS over 48 months.
@en
MRI correlates of disability progression in patients with CIS over 48 months.
@nl
type
label
MRI correlates of disability progression in patients with CIS over 48 months.
@ast
MRI correlates of disability progression in patients with CIS over 48 months.
@en
MRI correlates of disability progression in patients with CIS over 48 months.
@nl
prefLabel
MRI correlates of disability progression in patients with CIS over 48 months.
@ast
MRI correlates of disability progression in patients with CIS over 48 months.
@en
MRI correlates of disability progression in patients with CIS over 48 months.
@nl
P2093
P2860
P50
P1433
P1476
MRI correlates of disability progression in patients with CIS over 48 months.
@en
P2093
Deepa P Ramasamy
Eva Havrdova
Jan Krasensky
Manuela Vaneckova
Robert Zivadinov
Zdenek Seidl
P2860
P304
P356
10.1016/J.NICL.2014.09.015
P577
2014-09-28T00:00:00Z